Literature DB >> 17168757

G protein-activated inwardly rectifying potassium channels as potential therapeutic targets.

Toru Kobayashi1, Kazutaka Ikeda.   

Abstract

G protein-activated inwardly rectifying K(+) (GIRK; Kir3) channels regulate the neuronal activity and heart rate. Molecular cloning of the GIRK channel genes has led to remarkable progress in our understanding of the molecular structure, distribution and functional modulation of these channels. Furthermore, the roles of GIRK channels in vivo have been shown by studies using GIRK knockout mice and weaver mutant mice, which have a missense mutation in the GIRK2 gene. We also review the possible roles of GIRK channels in the pathophysiology of various disorders, and discuss the therapeutic potential of GIRK channel modulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17168757     DOI: 10.2174/138161206779010468

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  25 in total

1.  A fluorescent screening assay for identifying modulators of GIRK channels.

Authors:  Maribel Vazquez; Charity A Dunn; Kenneth B Walsh
Journal:  J Vis Exp       Date:  2012-04-24       Impact factor: 1.355

2.  Trisomy of the G protein-coupled K+ channel gene, Kcnj6, affects reward mechanisms, cognitive functions, and synaptic plasticity in mice.

Authors:  Ayelet Cooper; Gayane Grigoryan; Liora Guy-David; Michael M Tsoory; Alon Chen; Eitan Reuveny
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

3.  Go but not Gi2 or Gi3 is required for muscarinic regulation of heart rate and heart rate variability in mice.

Authors:  Sheng Zhong Duan; Michael Christe; David S Milstone; Richard M Mortensen
Journal:  Biochem Biophys Res Commun       Date:  2007-03-30       Impact factor: 3.575

Review 4.  Interaction of P2 purinergic receptors with cellular macromolecules.

Authors:  Laszlo Köles; Zoltan Gerevich; João Felipe Oliveira; Zoltan Sandor Zadori; Kerstin Wirkner; Peter Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-19       Impact factor: 3.000

5.  Discovery and Characterization of 1H-Pyrazol-5-yl-2-phenylacetamides as Novel, Non-Urea-Containing GIRK1/2 Potassium Channel Activators.

Authors:  Joshua M Wieting; Anish K Vadukoot; Swagat Sharma; Kristopher K Abney; Thomas M Bridges; J Scott Daniels; Ryan D Morrison; Kevin Wickman; C David Weaver; Corey R Hopkins
Journal:  ACS Chem Neurosci       Date:  2017-07-19       Impact factor: 4.418

6.  Inhibition of G-protein-activated inwardly rectifying K+ channels by the selective norepinephrine reuptake inhibitors atomoxetine and reboxetine.

Authors:  Toru Kobayashi; Kazuo Washiyama; Kazutaka Ikeda
Journal:  Neuropsychopharmacology       Date:  2010-03-10       Impact factor: 7.853

7.  Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology.

Authors:  Filip Simunovic; Ming Yi; Yulei Wang; Laurel Macey; Lauren T Brown; Anna M Krichevsky; Susan L Andersen; Robert M Stephens; Francine M Benes; Kai C Sonntag
Journal:  Brain       Date:  2008-12-03       Impact factor: 13.501

8.  Silencing the Kir4.1 potassium channel subunit in satellite glial cells of the rat trigeminal ganglion results in pain-like behavior in the absence of nerve injury.

Authors:  Jean-Philippe Vit; Peter T Ohara; Aditi Bhargava; Kanwar Kelley; Luc Jasmin
Journal:  J Neurosci       Date:  2008-04-16       Impact factor: 6.167

9.  Mechanisms underlying the activation of G-protein-gated inwardly rectifying K+ (GIRK) channels by the novel anxiolytic drug, ML297.

Authors:  Nicole Wydeven; Ezequiel Marron Fernandez de Velasco; Yu Du; Michael A Benneyworth; Matthew C Hearing; Rachel A Fischer; Mark John Thomas; C David Weaver; Kevin Wickman
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-07       Impact factor: 11.205

10.  Association between KCNJ6 (GIRK2) gene polymorphisms and postoperative analgesic requirements after major abdominal surgery.

Authors:  Daisuke Nishizawa; Makoto Nagashima; Ryoji Katoh; Yasuo Satoh; Megumi Tagami; Shinya Kasai; Yasukazu Ogai; Wenhua Han; Junko Hasegawa; Naohito Shimoyama; Ichiro Sora; Masakazu Hayashida; Kazutaka Ikeda
Journal:  PLoS One       Date:  2009-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.